Marco Mina is a computer scientist and computational biologist with 10+ years’ experience in Data Science, Bioinformatics and Computational Biology. After receiving his doctoral degree in Information Engineering from the University of Padova (Italy), Marco held a postdoctoral position in Cancer Genomics at the University of Lausanne, focusing on functional dependencies between cancer mutations and their therapeutic actionability. He later transitioned to industrial research at SOPHiA Genetics, leading a team focusing on variant annotation and pathogenicity prediction for the interpretation of patient molecular data. At HAYA Therapeutics, Marco is leading the Data Science and Computational Biology unit. His team focuses on multiple R&D aspects of the target discovery (HAYAtlas and DiscoverHAYA) and candidate nomination (ChemHAYA) platforms.
During his career, Marco published more than 20 articles (10+ as first co-author) in world-leading, peer-reviewed journals including Cell, Cancer Cell and Nature Genetics. His works have been cited more than 5’000 times.